Recent Episodes
Fri. 5/25/12
Week In Review
Fri. 5/25/12
Week In Review
The Emily Rooney Show
Public affairs professional Terence Burke, social critic and attorney Wendy Kaminer, and regular contributor to the Boston Globe Tom Keane weigh in on the week that was.
Thurs. 5/24/12
Is The Isabella Stewart Gardner Museum Heist Close To Being Solved?
Thurs. 5/24/12
Is The Isabella Stewart Gardner Museum Heist Close To Being Solved?
The Emily Rooney Show
We check in on recent developments in the Isabella Stewart Gardner heist with Tom Mashberg, who has been following the case for 22 years.
Thurs. 5/24/12
Local Scientist Redefines Brain Power
Thurs. 5/24/12
Local Scientist Redefines Brain Power
The Emily Rooney Show
We talk with the local scientist at the center of the development of the powerful new technology that allows paralyzed people to move objects – with their thoughts.
Thurs. 5/24/12
Show & Tell — Chloe Caldwell’s Legs Get Led Astray
Thurs. 5/24/12
Show & Tell — Chloe Caldwell’s Legs Get Led Astray
The Emily Rooney Show
Our resident provocateur talks about trends in young women's confessional literature, epitomized by Chloe Caldwell's frankly sexual writing.
Wed. 5/23/12
Pets, Etiquette And The Law
Wed. 5/23/12
Pets, Etiquette And The Law
The Emily Rooney Show
Kara Holmquist, MSPCA director of advocacy, and animal behaviorist Terri Bright take your questions about the line between rude and illegal when it comes to pet etiquette.
Wed. 5/23/12
The 30 Songs That Cost Joel Tenenbaum $675,000
Wed. 5/23/12
The 30 Songs That Cost Joel Tenenbaum $675,000
The Emily Rooney Show
Joel Tenenbaum, former BU Student who was sued by the RIAA, joins us to discuss the case.
Related Content
WAYH - Safeguarding The Safeguards Of Medicine
Ominous. That was the tone of conversation at a local biotech conference. With the purchase this month of Cambridge-based Genzyme by the French pharmaceutical giant Sanofi, local biotech executives are concerned that our smaller homegrown biotechs are increasing takeover targets by large multinational firms. While corporate ownership can bring funding and resources, scientist worry about losing the creative, entrepreneurial spirit that put Kendall Square on the biotech map. Christoph Westphal, chair of the venture capital firm, Longwood Founders Fund, joins us.












Podcast:
Friend: 




